AzTrials
AzTrials

Femoroacetabular ImpingementIMAHANCHENCT07271277

3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study

A study testing 3D MRI in people with Femoroacetabular Impingement, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Anterior cruciate ligament (ACL) tears are among the most common sports injuries. Numerous studies have shown that reduced hip rotation may play a role in ACL tears. The same question may also arise for hip injuries such as femoroacetabular impingement (FAI). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Femoroacetabular Impingement
What is being tested?
3D MRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
1 Oct 2026to 31 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient, male or female, aged 18 years or older
  • Patient with a primary complete ACL rupture
  • Patient affiliated with or covered by a social security scheme
  • Patient who speaks French and has signed an informed consent form

Who cannot join

  • Patient with multi-ligament injury
  • Patients with a history of hip fracture
  • Patients with a history of hip surgery
  • Patients with a contraindication to MRI
  • Protected individuals: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision
  • Pregnant or breastfeeding women

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bertrand SONNERY-COTTET, MD contact

+33 4 37 53 00 22

sonnerycottet@aol.com

France1 site
  • Hôpital Privé Jean Mermoz

    Lyon, France, 69008

    Bertrand SONNERY-COTTET, MD, + 33 4 37 53 00 22, sonnerycottet@aol.com

Other trials in France

About this study

Anterior cruciate ligament (ACL) tears are among the most common sports injuries. Numerous studies have shown that reduced hip rotation may play a role in ACL tears. The same question may also arise for hip injuries such as femoroacetabular impingement (FAI).

This research is based on the hypothesis that there is a relationship between FAI and ACL injury. In this context, 3D MRI of the hip would provide morphological details of the hip that are not currently available with other imaging techniques, thereby enabling early identification of FAI. This is the reason why this research has been initiated.

Read the detailed description

Anterior cruciate ligament (ACL) tears are among the most common sports injuries. It is estimated that approximately 150,000 ACL reconstructions are performed each year in the United States. Numerous studies have shown that reduced hip rotation may play a role in ACL tears. The same question may also arise for hip injuries such as femoroacetabular impingement (FAI).

This research is based on the hypothesis that there is a relationship between FAI and ACL injury. In this context, 3D MRI of the hip would provide morphological details of the hip that are not currently available with other imaging techniques, thereby enabling early identification of FAI. This is the reason why this research has been initiated.

Being tested
3D MRI
Keywords
femoroacetabular impingement
Medical subject headings
Femoracetabular Impingement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3D MRIOther

    Intervention consists of performing a 3D MRI scan of both hips using a T1 sequence.

Study groups in NCT07271277
Study groupRoleWhat they receive
FAI armExperimentalFAI arm involves patients with ACL rupture. A 3D MRI scan of both hips of theses patients will be performed.
Receives: Other: 3D MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FAI (femoroacetabular impingement) prevalence

    Prevalence of femoroacetabular impingement will be expressed as %. It will be measured on the injured knee side (i.e., ACL rupture) and on the healthy knee side (i.e., uninjured).

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2025
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion31 Jan 2028 (estimated)
  4. Study completion31 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07271277
Sponsor's protocol ID
2025-A01269-40
Acronym
IMAHANCHE
Status last verified
Aug 2026
First submitted
27 Nov 2025
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 3D MRI in people with Femoroacetabular Impingement, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bertrand SONNERY-COTTET, MD (+33 4 37 53 00 22, sonnerycottet@aol.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FAI (femoroacetabular impingement) prevalence (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in